Illumina (ILMN) expects adjusted EPS of approximately $4.50 for FY25
Biotechnology company Illumina, Inc. (NASDAQ: ILMN) has issued fresh earnings guidance for fiscal 2025, to reflect tariff-related challenges to export. The company said it expects fiscal year 2025 adjusted earnings to be approximately $4.50 per share The guidance came in response to a notice from the China Ministry of Commerce, restricting the export of sequencing … Read more